lapatinib has been researched along with Paronychia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belyayeva, Y; Gkouvi, A; Gregoriou, S; Katsambas, A; Larios, G; Rigopoulos, D | 1 |
| Frankel, C; Palmieri, FM | 1 |
2 review(s) available for lapatinib and Paronychia
| Article | Year |
|---|---|
Acute paronychia caused by lapatinib therapy.
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Lapatinib; Paronychia; Quinazolines | 2009 |
Lapatinib side-effect management.
Topics: Antineoplastic Agents; Diarrhea; Humans; Lapatinib; Paronychia; Protein-Tyrosine Kinases; Quinazolines; Skin Diseases | 2010 |